Autologous Stem Cell Transplantation: International Lupus Trial
Condition(s):REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLast Updated:October 1, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLast Updated:October 1, 2021Withdrawn
Condition(s):Covid19; Myeloma Multiple; Malignant Lymphoma; Hematologic Neoplasms; Stem Cell Transplant ComplicationsLast Updated:February 8, 2022Completed
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:March 16, 2022Terminated
Condition(s):LymphomaLast Updated:February 15, 2022Recruiting
Condition(s):Lupus NephritisLast Updated:February 4, 2019Completed
Condition(s):Complication of Transplanted Organ, NosLast Updated:April 28, 2021Completed
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:April 14, 2022Recruiting
Condition(s):Anemia; Lymphoma; Hematopoietic Stem Cell TransplantationLast Updated:January 5, 2017Unknown status
Condition(s):Triple-Negative Invasive Breast Carcinoma; Residual TumorLast Updated:January 14, 2020Unknown status
Condition(s):Crohn’s DiseaseLast Updated:April 15, 2016Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.